These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9458838)

  • 1. Hypoxia triggers release of an endogenous inhibitor of Na(+)-K(+)-ATPase from midbrain and adrenal.
    De Angelis C; Haupert GT
    Am J Physiol; 1998 Jan; 274(1):F182-8. PubMed ID: 9458838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic factor inhibits the (Na,K)ATPase from the extracellular surface. Mechanism of inhibition.
    Carilli CT; Berne M; Cantley LC; Haupert GT
    J Biol Chem; 1985 Jan; 260(2):1027-31. PubMed ID: 2981828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
    Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis.
    Zhao N; Lo LC; Berova N; Nakanishi K; Tymiak AA; Ludens JH; Haupert GT
    Biochemistry; 1995 Aug; 34(31):9893-6. PubMed ID: 7632688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of hypothalamic Na,K-ATPase inhibitor with isolated human peripheral blood mononuclear cells.
    Anner BM; Lacotte D; Anner RM; Moosmayer M
    Biosci Rep; 1994 Oct; 14(5):231-42. PubMed ID: 7772716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of a ouabain-like factor from Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbic acid: an endogenous inhibitor of isolated Na+,K+-ATPase.
    Ng YC; Akera T; Han CS; Braselton WE; Kennedy RH; Temma K; Brody TM; Sato PH
    Biochem Pharmacol; 1985 Jul; 34(14):2525-30. PubMed ID: 2990490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous ouabain: upregulation of steroidogenic genes in hypertensive hypothalamus but not adrenal.
    Murrell JR; Randall JD; Rosoff J; Zhao JL; Jensen RV; Gullans SR; Haupert GT
    Circulation; 2005 Aug; 112(9):1301-8. PubMed ID: 16116051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Na-K-ATPase activity after prolonged hypoxia in an alveolar epithelial cell line.
    Planès C; Friedlander G; Loiseau A; Amiel C; Clerici C
    Am J Physiol; 1996 Jul; 271(1 Pt 1):L70-8. PubMed ID: 8760134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific endogenous Na, K-ATPase inhibitor purified from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochem Biophys Res Commun; 1987 Dec; 149(2):468-74. PubMed ID: 2827643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic sodium-transport inhibitor is a high-affinity reversible inhibitor of Na+-K+-ATPase.
    Haupert GT; Carilli CT; Cantley LC
    Am J Physiol; 1984 Dec; 247(6 Pt 2):F919-24. PubMed ID: 6095682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bufodienolides as endogenous Na+, K+-ATPase inhibitors: biosynthesis in bovine and rat adrenals.
    Lichtstein D; Steinitz M; Gati I; Samuelov S; Deutsch J; Orly J
    Clin Exp Hypertens; 1998; 20(5-6):573-9. PubMed ID: 9682913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a ouabain-like compound from human plasma.
    Hamlyn JM; Blaustein MP; Bova S; DuCharme DW; Harris DW; Mandel F; Mathews WR; Ludens JH
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6259-63. PubMed ID: 1648735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
    Hallaq HA; Haupert GT
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10080-4. PubMed ID: 2557617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin-binding antibodies reverse the effect of endogenous digitalis-like compounds on Na,K-ATPase in erythrocytes.
    Balzan S; Montali U; Biver P; Ghione S
    J Hypertens Suppl; 1991 Dec; 9(6):S304-5. PubMed ID: 1668002
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypothalamic Na+,K(+)-ATPase inhibitor constricts pulmonary arteries of spontaneously hypertensive rats.
    Janssens SP; Kachoris C; Parker WL; Hales CA; Haupert GT
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S42-6. PubMed ID: 7508026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel endogenous sodium-pump inhibitor in pig urine: purification and comparison with the inhibitor purified from bovine adrenal glands.
    Tamura M; Konishi F; Inagami T
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S47-50. PubMed ID: 7508027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ouabain-binding protein(s) from human plasma.
    Parhami-Seren B; Haberly R; Margolies MN; Haupert GT
    Hypertension; 2002 Aug; 40(2):220-8. PubMed ID: 12154117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual effect of digitalis glycosides on norepinephrine release from human atrial tissue and bovine adrenal chromaffin cells: differential dependence on [Na+]i and [Ca2+]i.
    Haass M; Serf C; Gerber SH; Krüger C; Haunstetter A; Vahl CF; Nobiling R; Kübler W
    J Mol Cell Cardiol; 1997 Jun; 29(6):1615-27. PubMed ID: 9220347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.